PL372137A1 - Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny - Google Patents

Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny

Info

Publication number
PL372137A1
PL372137A1 PL01372137A PL37213701A PL372137A1 PL 372137 A1 PL372137 A1 PL 372137A1 PL 01372137 A PL01372137 A PL 01372137A PL 37213701 A PL37213701 A PL 37213701A PL 372137 A1 PL372137 A1 PL 372137A1
Authority
PL
Poland
Prior art keywords
sertraline hydrochloride
novel
preparation
composition containing
amorphous form
Prior art date
Application number
PL01372137A
Other languages
English (en)
Inventor
Eduard Schwartz
Tamar Nidam
Anita Liberman
Marioara Mendelovici
Judith Aronhime
Claude Singer
Evgeni Valdman
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Priority to PL01372137A priority Critical patent/PL372137A1/pl
Publication of PL372137A1 publication Critical patent/PL372137A1/pl

Links

PL01372137A 2001-12-13 2001-12-13 Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny PL372137A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL01372137A PL372137A1 (pl) 2001-12-13 2001-12-13 Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL01372137A PL372137A1 (pl) 2001-12-13 2001-12-13 Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny

Publications (1)

Publication Number Publication Date
PL372137A1 true PL372137A1 (pl) 2005-07-11

Family

ID=35784537

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01372137A PL372137A1 (pl) 2001-12-13 2001-12-13 Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny

Country Status (1)

Country Link
PL (1) PL372137A1 (pl)

Similar Documents

Publication Publication Date Title
EP1463711A4 (en) "NEW POLYMORPH OF SERTRALINE HYDROCHLORIDE AND COMPOSITION CONTAINING THEREOF, NEW METHODS OF PREPARING SERTRALINE HYDROCHLORIDE POLYMORPHES AND AMORPH FORM"
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
HUP0203559A3 (en) Polymorphic forms of sertraline hydrochloride, process for their preparation and pharmaceutical compositions containing them
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
HUP0200438A3 (en) Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
ZA200401806B (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
HUP0400208A3 (en) N-formyl hydroxylamine compounds, process for their preparation and pharmaceutical compositions containing them
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
EP1289928A4 (en) NEW AMORPHOUS FORM OF SERTRALINE HYDROCHLORIDE
IL162171A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002305162A1 (en) Polymorphs of fexofenadine hydrochloride
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
PL372137A1 (pl) Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny
AU2002356425A8 (en) A process for manufacture of a sustained release composition containing microbe
AU2003243153A8 (en) Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
PL2181982T3 (pl) Sposób wytwarzania chlorowodorku wenlafaksyny w formie I
PL376832A1 (pl) Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny
HK1056545A (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
HK1065777A (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
HK1050320A (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
HUP0301331A3 (en) Antipicornaviral compounds process for their preparation and compositions containing them, their pharmaceutical uses, and intermediates for their synthesis
AU2002308095A1 (en) Process for preparing sertraline hydrochloride polymorphic form ii
HUP0104872A3 (en) New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)